Inoperable lung cancer causes leukemia and prostate

Jul 26
19:14

2008

Jay Moncliff

Jay Moncliff

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

Lung cancer is one of the most deadly types of cancer that cause damage to the lungs of a person. The treatment procedures adopted to cure the disease depends upon the stage of its formation. Knee arthritis is one of the first signs.

mediaimage

Surgery for lung cancer remains an option for the patients suffering from lung cancer with stage I and II i.e. the early stage NSCLC (non-small cell lung cancer). Nevertheless,Inoperable lung cancer causes leukemia and prostate Articles substantial amounts of individuals suffering from cancer are medically inoperable lung cancer due to various medical conditions and failure that can lead to several kinds of complications and even death after the surgery. Prostate, leukemia, ibs carcinomas are some of the types of cancer and low energy, congestive breathing and bronchitis are some of the signs and symptoms of cancer. However, if seen in child at any stage must be cured as soon as possible in order to avoid further complications. Narcolepsy is one medicine such that has been proved highly beneficial to treat the problem of cancer.                    Medically inoperable lung cancer in the early stage has several treatment alternatives including chemotherapy, radiation therapy, radiofrequency ablation, targeted therapy and cryotherapy. RFA or radiofrequency ablation is a method under which the heat is used in order to kill the cancer or a tumor. Initially, the cancer is localized by a computed technology- CT or an ultra sound and after that, a thin needle is placed in via the skin in the tumor. The electric energy supplied via the thin needle heat the cancer/tumor to a temperature of almost hundred degrees Celsius, thereby killing the cells of the cancer in the tumor. Nevertheless, RFA is suitable for the small size tumor and situated away from the vital organs in chest like main blood vessels, central airways and heart. Risk from this method includes problems in breathing because of the accumulation of fluid or air in chest cavity or bleeding in the lung.                            The potential advantage from enhancing the radiation doses to the cells of the cancer should be controlled and balanced over the risk of injury to the normal tissues of the body including the uncomplicated normal heart, lung, spinal cord and esophagus. However the risk of the radiation negative effects depend on total volume of the dose of the radiation, the volume of dose in every session and also the volume of the normal tissues that are exposed to the radiation. The radiation could cause inflammation of lungs, scarring of lungs, which further creates shortness of breath, worsens the pulmonary function tests, and might need oxygen treatments on a permanent or on a temporary basis. Radiation injury to the tube of the food between the stomach and the mouth might result in hurting swallowing and narrowing of esophagus that might compromise nutrition. The risk of radiation injury with greater radiation dose underscores the necessity for novel radiation therapy procedure which target the tumor more accurately while least exposure to the normal tissues of the body.                                                The three dimensional radiation therapy techniques traditionally have been used in order to cure the patients with the medically inoperable lung cancer with stage I and II non-small cell lung cancer. This technique enables the physicians to visualize the cancer tumor and the normal tissues in the three dimensions and calculate the radiation doses according to the whole volume of the tumor and to lessen down the damage. A comparatively low dose of the 2 Gy is generally applied to the cells of the cancer every day on the course of five to seven weeks in order to supply the total dose of 50-70 Gy. Reviews of the patients outcomes treated through this method indicate overall survival rates upto fifty five to thirty two percent at three to five years.